These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4720815)

  • 1. Monitoring phenylalanine-tyrosine metabolism by high-resolution liquid chromatography of urine.
    Mrochek JE; Dinsmore SR; Ohrt DW
    Clin Chem; 1973 Aug; 19(8):927-36. PubMed ID: 4720815
    [No Abstract]   [Full Text] [Related]  

  • 2. The investigation of aromatic acids in phenylketonuria, alkaptonuria and tyrosinosis using gas-liquid chromatography.
    Hill A; Hoag GN; Zaleski WA
    Clin Chim Acta; 1972 Mar; 37():455-62. PubMed ID: 5022110
    [No Abstract]   [Full Text] [Related]  

  • 3. Iso-homovanillic acid determination in cerebrospinal fluid and in urine during L-DOPA treatment of Parkinson's disease.
    Ebinger G; Adriaenssens K
    Clin Chim Acta; 1973 Nov; 48(4):427-31. PubMed ID: 4761590
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-related alterations in metabolism of levodopa: possible mechanism for hypotensive effect.
    Kochar MS; Itskovitz HD; Sasse EA; Baker JD; Doumas BT
    J Clin Pharmacol; 1974; 14(8):448-54. PubMed ID: 4851433
    [No Abstract]   [Full Text] [Related]  

  • 5. Aromatic acid excretion in phenylketonuria. Analysis of the unconjugated aromatic acids derived from phenylalanine.
    Blau K
    Clin Chim Acta; 1970 Jan; 27(1):5-18. PubMed ID: 5412612
    [No Abstract]   [Full Text] [Related]  

  • 6. The excretion of L-dopa metabolites at different hours of the day.
    Aguggini G; Meucci M; Reina G
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):749-57. PubMed ID: 4629113
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple and rapid gas chromatography for determining 3,4-dihydroxyphenylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid in urine from patients with parkinsonism treated with L-3,4-dihydroxyphenylalanine.
    Fukaya J; Imai K; Tamura Z
    Clin Chim Acta; 1971 Jul; 33(2):470-2. PubMed ID: 5119325
    [No Abstract]   [Full Text] [Related]  

  • 8. Separation and determination of urinary homovanillic acid and iso-homovanillic acid by gas-liquid chromatography and electron capture detection.
    Dziedzic SW; Dziedzic LB; Gitlow SE
    J Lab Clin Med; 1973 Nov; 82(5):829-35. PubMed ID: 4746822
    [No Abstract]   [Full Text] [Related]  

  • 9. Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load.
    Rampini S; Völlmin JA; Bosshard HR; Müller M; Curtius HC
    Pediatr Res; 1974 Jul; 8(7):704-9. PubMed ID: 4837567
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.
    Curtius HC; Völlmin JA; Baerlocher K
    Clin Chim Acta; 1972 Mar; 37():277-85. PubMed ID: 5022091
    [No Abstract]   [Full Text] [Related]  

  • 11. Variation of levodopa metabolism with gastrointestinal absorption site.
    Sandler M; Ruthven CR; Goodwin BL; Hunter KR; Stern GM
    Lancet; 1974 Feb; 1(7851):238-40. PubMed ID: 4130247
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
    [No Abstract]   [Full Text] [Related]  

  • 13. 2,3,5-Trihydroxyphenylacetic acid. A metabolite of L-3,4-dihydroxyphenylalanine.
    Wada GH; Fellman JH
    Biochemistry; 1973 Dec; 12(25):5212-7. PubMed ID: 4799943
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.
    Mars H
    Arch Neurol; 1974 Jun; 30(6):444-7. PubMed ID: 4827061
    [No Abstract]   [Full Text] [Related]  

  • 15. The simultaneous determination by selected ion monitoring of the levels of homovanillic, isohomovanillic, 3,4-dihydroxyphenylacetic and 3-methoxy-4-hydroxymandelic acids in single biological samples.
    Narasimhachari N; Leiner K; Brown C
    Clin Chim Acta; 1975 Jul; 62(2):245-53. PubMed ID: 807438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
    Sandler M; Johnson RD; Ruthven CR; Reid JL; Calne DB
    Nature; 1974 Feb; 247(5440):364-6. PubMed ID: 4817854
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal organic acidurias in mentally retarded patients.
    Watts RW; Chalmers RA; Lawson AM
    Lancet; 1975 Feb; 1(7903):368-72. PubMed ID: 46515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid in human urine by high-performance liquid chromatography and fluorometry.
    Wielders JP; Mink JK
    J Chromatogr; 1984 Oct; 310(2):379-85. PubMed ID: 6210297
    [No Abstract]   [Full Text] [Related]  

  • 19. Aromatic acid excretion in classical phenylketonuria and hyperphenylalaninemic variants.
    Koepp P; Hoffmann B
    Helv Paediatr Acta; 1974 Nov; 29(5):489-98. PubMed ID: 4452644
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative analysis of phenylalanine metabolites in urine to detect heterozygotes of phenylketonuria.
    Olek K; Oyanagi K; Wardenbach P
    Humangenetik; 1974 Apr; 22(1):85-8. PubMed ID: 4837293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.